跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TECARTUS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TECARTUS
Authorized
STANDARD
TECARTUS
gilead sciences canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
ae4ad9f040ec324b
Company
gilead sciences canada inc
Type
Standard
Approval Details
Approval Id
ae4ad9f040ec324b
Drug Approval Canada Name
TECARTUS
Product Name
TECARTUS
Status
Marketed
Status Date
2023-12-15
Original Market Date
2023-12-15
Din
02532719
Drug Class
Human
Dosage Form
Suspension
Route Of Administration
Intravenous
Schedule
Prescription , Schedule D
Ahfs
26:12.00
Atc Original
L01XL06 BREXUCABTAGENE AUTOLEUCEL
Atc Name
l 01 xl 06
Aig Number
0162968002
Company Name
gilead sciences canada inc
Company Address
400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2
Active Ingredients
BREXUCABTAGENE AUTOLEUCEL
100000000 CELLS / BAG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
ae4ad9f040ec324b
Type
Standard
Back to Health Canada Approvals